Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Accepts healthy volunteers

The STRIVE Study: Development of a Blood Test for Early Detection of Multiple Cancer Types

ClinicalTrials.gov ID: NCT03085888

Public ClinicalTrials.gov record NCT03085888. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 4:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The STRIVE Study: Breast Cancer Screening Cohort for the Development of Assays for Early Cancer Detection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

GRAIL is using high-intensity sequencing of circulating cell-free nucleic acids (cfNAs) to develop blood tests to detect cancer early. The purpose of this study is to validate the ability of the pre-specified GRAIL Test to detect breast cancer and other invasive cancers, including hematologic malignancies, that will occur within one year of the first study blood draw.

Study identification

NCT ID
NCT03085888
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
GRAIL, Inc.
Industry
Enrollment
99,481 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2017 (Actual)
Primary completion
Jun 30, 2022 (Actual)
Completion
Apr 1, 2024 (Actual)
Last update posted
Sep 20, 2024

2017 – 2024

United States locations

U.S. sites
35
U.S. states
15
U.S. cities
34
Facility City State ZIP Site status
Mayo Clinic Phoenix Arizona 85054 —
Scottsdale Medical Imaging Research Scottsdale Arizona 85258 —
Sutter Health Elk Grove California 95758 —
Sutter Health Folsom California 95630 —
Sutter Health Mountain View California 94040 —
Sutter Health Oakland California 94609 —
Sutter Health Palo Alto California 94301 —
Sutter Health Roseville California 95661 —
Sutter Health Sacramento California 95816 —
Sutter Health San Francisco California 94118 —
Sutter Health San Mateo California 94401 —
Sutter Health Santa Cruz California 95062 —
Sutter Health Santa Rosa California 95403 —
Mayo Clinic Jacksonville Florida 32224 —
Sarah Cannon Research Institute Snellville Georgia 30078 —
Sarah Cannon Research Institute Overland Park Kansas 66209 —
Henry Ford Health System Dearborn Michigan 48126 —
Henry Ford Health System Detroit Michigan 48202 —
Henry Ford Health System Grosse Pointe Farms Michigan 48326 —
Henry Ford Health System Livonia Michigan 48150 —
Mayo Clinic Rochester Minnesota 32224 —
Sarah Cannon Research Institute Independence Missouri 64057 —
Cleveland Clinic Avon Ohio 44011 —
Cleveland Clinic Beachwood Ohio 44122 —
Cleveland Clinic Cleveland Ohio 44195 —
Sarah Cannon Research Institute Charleston South Carolina 29406 —
Sarah Cannon Research Institute Hermitage Tennessee 37076 —
Sarah Cannon Research Institute Nashville Tennessee 37203 —
Sarah Cannon Research Institute McKinney Texas 75069 —
Sarah Cannon Research Institute Salt Lake City Utah 84124 —
Sarah Cannon Research Institute Richmond Virginia 23229 —
Sarah Cannon Research Institute Richmond Virginia 23235 —
Sarah Cannon Research Institute Salem Virginia 24153 —
Mayo Clinic Eau Claire Wisconsin 54702 —
Mayo Clinic La Crosse Wisconsin 54601 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03085888, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 20, 2024 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03085888 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →